Dr. Tabayoyong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-275-2838Fax+1 585-273-1068
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Urology, 2012 - 2017- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Transitional Year, 2011 - 2012
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2011
Certifications & Licensure
NY State Medical License 2019 - 2025
OH State Medical License 2011 - 2017- American Board of Urology Urology
Publications & Presentations
PubMed
- 19 citationsCurrent Use and Promise of Urinary Markers for Urothelial Cancer.William Tabayoyong, Ashish M. Kamat
Current Urology Reports. 2018-10-17 - 15 citationsVariability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members.Justin T. Matulay, William Tabayoyong, Jonathan J. Duplisea, Courtney M Chang, Siamak Daneshmand
Urologic Oncology. 2020-05-17 - 115 citationsDevelopment of a combined Mr Fingerprinting and Diffusion examination for Prostate cancerAlice C. Yu, Chaitra Badve, Lee Ponsky, Shivani Pahwa, Sara Dastmalchian
Radiology. 2017-02-10
Authored Content
- Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non–Muscle-Invasive Bladder CancerSeptember 2018
Grant Support
- NK And T Cell Regulation Of Es-Derived Hematopoietic Progenitor Cell EngraftmentNational Heart, Lung, And Blood Institute2009–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
